Skip to main content
NASDAQ:PAND

Pandion Therapeutics Short Interest Ratio and Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.
$60.05
0.00 (0.00 %)
(As of 04/1/2021)
Add
Compare
Today's Range
$60.05
$60.05
50-Day Range
$59.90
$60.28
52-Week Range
$10.28
$62.90
VolumeN/A
Average Volume355,921 shs
Market Capitalization$1.77 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Short Interest

Pandion Therapeutics (NASDAQ:PAND) Short Interest Data

Current Short Volume411,800 shares
Previous Short Volume961,000 shares
Change Vs. Previous Month-57.15%
Dollar Volume Sold Short$24.72 million
Short Interest Ratio / Days to Cover1.2
Last Record DateMarch, 15 2021
Outstanding Shares29,516,000 shares
Percentage of Shares Shorted1.40%
Today's Trading Volume0 shares
Average Trading Volume355,921 shares
Today's Volume Vs. Average-100.00%

Short Interest Over Time


Pandion Therapeutics (NASDAQ:PAND) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/2021411,800 shares $24.72 million -57.2%N/A1.2 $60.03
2/26/2021961,000 shares $57.48 million +98.7%N/A3.3 $59.81
2/12/2021483,700 shares $9.46 million +50.1%4.1%4.1 $19.55
1/29/2021322,200 shares $5.77 million -17.9%2.8%3.5 $17.90
1/15/2021392,200 shares $7.37 million No Change3.3%4.5 $18.79

Pandion Therapeutics (NASDAQ:PAND) Short Interest FAQ

speech bubbles
speech bubbles











What is Pandion Therapeutics' current short interest?

Short interest is the volume of Pandion Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 411,800 shares of PAND short.

What is a good short interest ratio for Pandion Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Pandion Therapeutics currently has a short interest ratio of 1.0.

Is Pandion Therapeutics' short interest increasing or decreasing?

Pandion Therapeutics saw a decline in short interest during the month of March. As of March 15th, there was short interest totaling 411,800 shares, a decline of 57.1% from the previous total of 961,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Pandion Therapeutics' short interest compare to its competitors?

0.00% of Pandion Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Pandion Therapeutics: GW Pharmaceuticals plc (0.00%), Perrigo Company plc (3.69%), Sarepta Therapeutics, Inc. (0.00%), Blueprint Medicines Co. (0.00%), Allakos Inc. (9.33%), Ionis Pharmaceuticals, Inc. (6.40%), Galapagos NV (0.00%), TG Therapeutics, Inc. (9.14%), I-Mab (0.00%), and Biohaven Pharmaceutical Holding Company Ltd. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($9.74 billion), Aon plc ($5.63 billion), Charter Communications, Inc. ($5.41 billion), Analog Devices, Inc. ($5.32 billion), Baidu, Inc. ($4.45 billion), Snap Inc. ($3.86 billion), Discovery, Inc. ($3.30 billion), Airbnb, Inc. ($2.82 billion), GameStop Corp. ($2.70 billion), and Bilibili Inc. ($2.34 billion). View all of the most shorted stocks.

What does it mean to sell short Pandion Therapeutics stock?

Short selling PAND is an investing strategy that aims to generate trading profit from Pandion Therapeutics as its price is falling. To short Pandion Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Pandion Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Pandion Therapeutics?

A short squeeze for Pandion Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PAND, which in turn drives the price of the stock up even further.

How often is Pandion Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PAND, twice per month. The most recent reporting period available is March, 15 2021.



This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.